An Essential Role for Fibronectin Extra Type III Domain A in Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Rationale: Tissue fibrosis is considered a dysregulated wound-healing response. Fibronectin containing extra type III domain A (EDA) is implicated in the regulation of wound healing. EDA-containing fibronectin is deposited during wound repair, and its presence precedes that of collagen. Objectives: To investigate the role of EDA-containing fibronectin in lung fibrogenesis. Methods: Primary lung fibroblasts from patients with idiopathic pulmonary fibrosis or from patients undergoing resection for lung cancer were assessed for EDA-containing fibronectin and α-smooth muscle actin (α-SMA) expression. Mice lacking the EDA domain of fibronectin and their wild-type littermates were challenged with the bleomycin model of lung fibrosis. Primary lung fibroblasts from these mice were assayed in vitro to determine the contribution of EDA-containing fibronectin to fibroblast phenotypes. Measurements and Main Results: Idiopathic pulmonary fibrosis lung fibroblasts produced markedly more EDA-containing fibronectin and α-SMA than control fibroblasts. EDA-null mice failed to develop significant fibrosis 21 days after bleomycin challenge, whereas wild-type controls developed the expected increase in total lung collagen. Histologic analysis of EDA-null lungs after bleomycin showed less collagen and fewer α-SMA–expressing myofibroblasts compared with that observed in wild-type mice. Failure to develop lung fibrosis in EDA-null mice correlated with diminished activation of latent transforming growth factor (TGF)-β and decreased lung fibroblast responsiveness to active TGF-β in vitro. Conclusions: The data show that EDA-containing fibronectin is essential for the fibrotic resolution of lung injury through TGF-β activation and responsiveness, and suggest that EDA-containing fibronectin plays a critical role in tissue fibrogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the abovementioned effects, TGFβ can induce the expression of fibronectin 1 extra domain A (FN1 EDA) in (myo) fibroblasts. FN1 EDA is a splice variant of fibronectin which contains the so-called EDA domain. Normally, FN1 EDA is not expressed in healthy tissues but its expression is induced during wound healing (65) Fibroblasts can detect FN1 EDA via membrane bound receptors such as α4”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [67]
Citations
Cites
1 retracted
Matsuyama, W., Watanabe, M., Shirahama, Y., Mitsuyama, H., Higashimoto, I., Osame, M., & Arimura, K. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050801 · Cited by 22 · cited 4×
“cocultured overnight on TCP (2) or EDA-containing cFN (1) with mink”
BackgroundMethodResultInfluentialRetractedMunger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 6×
“Notably, Munger and colleagues have previously demonstrated that mice lacking the b6-integrin develop inflammation in the lung after bleomycin, which does not transition to a fibrotic response (17).”
BackgroundMethodResultInfluentialSelf-citationKulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967 · cited 1×
“Similar findings are observed to occur spontaneously in the lungs and hearts of mice with a targeted deletion of the TGF-b1 gene (26).”
ResultPankov, R., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 1,953 · cited 5×
“Two main forms of FN exist: plasma FN, a dimeric and soluble form produced by hepatocytes that lacks the EDA and EDB sequences, and cellular FN (cFN), a multimeric form synthesized by mesenchymal, epithelial, and inflammatory cells, which is deposited in ECM fibrils and that contains variable proportions of the extra…”
BackgroundInfluentialSerini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847 · cited 5×
“Although the function or functions of these domains have not been fully elucidated, attention has focused on the contribution of EDA-containing FN (EDA cFN) in fibroblast activation ( 6 ) and in wound healing (7).”
BackgroundResultInfluentialBroekelmann, T. J., Limper, A. H., Colby, T. V., & McDonald, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6642 · Cited by 794 · cited 1×
“Therefore, because TGF-b is present at sites of fibrosis (12) and is a profibrotic growth factor, one of the pathways by which TGF-b promotes fibrogenesis could be via the induction of EDA cFN, which in turn promotes differentiation of mesenchymal cells into fibrogenic myofibroblasts.”
BackgroundMechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Lyons, R. M., Gentry, L. E., Purchio, A. F., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.4.1361 · Cited by 737 · cited 1×
“Activation of TGF-b requires conformational changes that allow TGF-b receptors to access the mature TGF-b, which can occur under acid conditions, via avb6 or other integrins (17) or via plasmin (20).”
BackgroundResolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677 · cited 1×
“Interestingly, genetic knockout of CD44, a membrane receptor for the ECM protein hyaluronan, also results in an exaggerated inflammatory response without resultant fibrosis in the lung after bleomycin (27); evidence suggests that this may be in part due to CD44 regulation of TGF-b1 production (28), again highlighting…”
BackgroundThe pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed Central · Cited by 549
Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.
Ffrench-Constant, C., Van de Water, L., Dvorak, H. F., & Hynes, R. O. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.2.903 · Cited by 486 · cited 1×
“The concept that alternative splicing of FN in general, and EDA cFN in particular, is essential in wound healing has been well established by our group and others (7, 38, 39).”
BackgroundKuhn, C., & McDonald, J. A. (1991) · PubMed · Cited by 472
Kuhn, C., Boldt, J., King, T. E., Crouch, E., Vartio, T., & McDonald, J. A. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.6.1693 · Cited by 466
Mechanisms of tissue repair: from wound healing to fibrosis
Mutsaers, S. E., Bishop, J. E., McGrouther, G., & Laurent, G. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00115-x · Cited by 454 · cited 1×
“The pathogenesis of progressive tissue fibrosis is incompletely understood, but has been likened to an exuberant and dysregulated wound-healing response (22).”
BackgroundInfluence of RNA Secondary Structure on the Pre-mRNA Splicing Process
Buratti, E., & Baralle, F. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10505-10514.2004 · Cited by 427 · cited 1×
“Physiologic (or pathologic) factors that induce EDA cFN production are poorly defined, although the molecular mechanisms regulating alternative EDA exon splicing have been well described (8, 9 ). Interestingly, one known factor that promotes EDA inclusion into FN is transforming growth factor (TGF)-b1, a cytokine impl…”
BackgroundSelf-citationTransient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice
Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., & Iwamoto, I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6094 · Cited by 405 · cited 1×
“Because TGF-b is likely involved in the pathogenesis of bleomycin-induced pulmonary fibrosis (36), our data appear to bolster the contention that EDA cFN is a requisite factor for TGF-b–induced a-SMA expression in vivo.”
ResultMuro, A. F., Chauhan, A. K., Gajovic, S., Iaconcig, A., Porro, F., Stanta, G., & Baralle, F. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212079 · Cited by 319 · cited 5×
“We have previously shown that EDA2/2 mice are incapable of adequately healing cutaneous wounds (7) due to ulceration of the newly formed epidermis, abnormal reepithelialization, and ongoing proliferation of infiltrating inflammatory cells.”
BackgroundInfluentialSelf-citationBurgess, H. A., Daugherty, L. E., Thatcher, T. H., Lakatos, H. F., Ray, D. M., Redonnet, M., Phipps, R. P., & Sime, P. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00383.2004 · Cited by 317 · cited 1×
“Physiologic (or pathologic) factors that induce EDA cFN production are poorly defined, although the molecular mechanisms regulating alternative EDA exon splicing have been well described (8, 9). Interestingly, one known factor that promotes EDA inclusion into FN is transforming growth factor (TGF)-b1, a cytokine impli…”
BackgroundKolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0243oc · Cited by 294 · cited 1×
“In support of these possibilities, Riquet and colleagues (29) and our own group (30) have shown that prostaglandin E2 is a potent suppressor of both a-SMA and Figure 6.”
BackgroundSelf-citationBleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 265 · cited 1×
“075 U/mouse (‘‘high dose,’’ corresponding to three times the ‘‘standard’’ dose), a dose expected to induce mortality rates of 35–40% (21).”
Self-citationWhite, E. S., Atrasz, R. G., Hu, B., Phan, S. H., Stambolic, V., Mak, T. W., Hogaboam, C. M., Flaherty, K. R., Martinez, F. J., Kontos, C. D., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1058oc · Cited by 204 · cited 5×
“Immunohistochemistry on paraffin-embedded sections was performed as previouslydescribed( 16 )withMasson’strichrome,orwithanti‐a-smooth muscle actin (anti‐a-SMA) antibody (clone 1A4; Dako Corporation, Carpinteria,CA)oranti‐phospho-Smad2antibody(catalogno.3101;Cell SignalingTechnology,Beverly,MA)followedbycolordevelopme…”
MethodInfluentialSelf-citationFuruhashi, M., Sjöblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H., Bergsten-Folestad, E., Eriksson, U., Heuchel, R., Betsholtz, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1489 · Cited by 203 · cited 1×
“Notably, Ball and colleagues recently reported the ability of platelet-derived growth factor (PDGF) receptor to directly up-regulate mesenchymal stem cell a-SMA expression by an RhoA/ROCK/cofilindependent mechanism (34), and PDGF has been shown to be secreted by certain neoplasms as a means to promote pericyte recruit…”
BackgroundModulation of Cell-adhesive Activity of Fibronectin by the Alternatively Spliced EDA Segment
Manabe, R.-I., Oh-e, N., Maeda, T., Fukuda, T., & Sekiguchi, K. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.295 · Cited by 195 · cited 1×
“EDA cFN (also termed oncofetal or embryonic FN) is an important substrate for cell migration (40), adhesion (41), and myofibroblast differentiation (Reference 6 and data presented here).”
BackgroundWhite, E. S., Thannickal, V. J., Carskadon, S. L., Dickie, E. G., Livant, D. L., Markwart, S., Toews, G. B., & Arenberg, D. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-041oc · Cited by 147 · cited 1×
“Primary Lung Fibroblast Isolation Primary human lung fibroblasts and lung fibroblasts from EDA2/2 and wild-type (WT) mice were isolated as we have previously described ( 14 ).”
MethodSelf-citationMuro, A. F., Caputi, M., Pariyarath, R., Pagani, F., Buratti, E., & Baralle, F. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2657 · Cited by 134 · cited 1×
“Physiologic (or pathologic) factors that induce EDA cFN production are poorly defined, although the molecular mechanisms regulating alternative EDA exon splicing have been well described (8, 9).”
BackgroundSelf-citationTransforming growth factor‐β regulates the splicing pattern of fibronectin messenger RNA precursor
Borsi, L., Castellani, P., Risso, A. M., Leprini, A., & Zardi, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80664-5 · Cited by 125
A Major Fraction of Fibronectin Present in the Extracellular Matrix of Tissues Is Plasma-derived
Moretti, F. A., Chauhan, A. K., Iaconcig, A., Porro, F., Baralle, F. E., & Muro, A. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611315200 · Cited by 119 · cited 1×
“Recently, our group has shown that a substantial portion of extracellular FN is derived from plasma (37).”
BackgroundSelf-citationGharaee‐Kermani, M., Gyetko, M. R., Hu, B., & Phan, S. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9216-x · Cited by 112 · cited 4×
“cocultured overnight on TCP (2) or EDA-containing cFN (1) with mink”
BackgroundMethodResultInfluentialAstrof, S., Crowley, D., George, E. L., Fukuda, T., Sekiguchi, K., Hanahan, D., & Hynes, R. O. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8662-8670.2004 · Cited by 108 · cited 1×
“Although EDA cFN was shown to be necessary for TGF-b–induced a-SMA augmentation in myofibroblasts (6), a previous report in EDA2/2 mice demonstrated no defect in aSMA induction in pericytes during tumor angiogenesis (33).”
ResultSisson, T. H., Hattori, N., Xu, Y., & Simon, R. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016960 · Cited by 104 · cited 1×
“Collagen content was measured in lungs via a conventional hydroxyproline assay ( 18 ).”
MethodGlutathione regulates transforming growth factor-β-stimulated collagen production in fibroblasts
Liu, R.-M., Liu, Y., Forman, H. J., Olman, M. A., & Tarpey, M. M. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00231.2003 · Cited by 101
Koukoulis, G. Κ., Howeedy, A. A., Korhonen, M. O., Virtanen, I., & Gould, V. E. (1993) · PubMed · Cited by 74
Hernnas, J., Nettelbladt, O., Bjermer, L., Sarnstrand, B., Malmstrom, A., & Hallgren, R. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05040404 · Cited by 73 · cited 3×
“In experimental models, EDA cFN expression occurs early after lung injury, preceding collagen deposition (3).”
BackgroundResultBall, S. G., Shuttleworth, C. A., & Kielty, C. M. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.09.005 · Cited by 68 · cited 1×
“Notably, Ball and colleagues recently reported the ability of platelet-derived growth factor (PDGF) receptor to directly up-regulate mesenchymal stem cell a-SMA expression by an RhoA/ROCK/cofilindependent mechanism ( 34 ), and PDGF has been shown to be secreted by certain neoplasms as a means to promote pericyte recru…”
BackgroundRiquet, F. B., Lai, W. T., Birkhead, J. R., Suen, L.-F., Karsenty, G., & Goldring, M. B. (2000) · Molecular Medicine · doi:10.1007/bf03402050 · Cited by 58
Rameshwar, P., Chang, V. T.-S., & Gascón, P. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4631004.x · Cited by 47
Chauhan, A. K., Iaconcig, A., Baralle, F. E., & Muro, A. F. (2003) · Gene · doi:10.1016/j.gene.2003.09.026 · Cited by 40 · cited 1×
“Although it is possible that lack of EDA FN in EDA2/2 mice resulted in an overexpression of the EDB and subsequent phenotypic differences, our group has previously shown that EDA and EDB alternative splicing are completely autonomous (25), thus diminishing the likelihood of this occurring.”
BackgroundSelf-citationSELECTIVE INHIBITION OF COLLAGEN GENE EXPRESSION IN FIBROBLASTS BY AN INTERFERON-gamma TRANSGENE
Jaffe, Z. G. H. A. (1999) · Experimental Lung Research · doi:10.1080/019021499270268 · Cited by 39 · cited 1×
“Similarly, Jaffe and colleagues have shown that murine fibroblasts infected with adenovirus encoding murine IFN-g results in a selective inhibition of procollagen I mRNA and secretion of total collagen compared with uninfected cells (31).”
BackgroundEmbryonic fibronectins are up‐regulated following peripheral nerve injury in rats
Mathews, G. A., & ffrench‐Constant, C. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260203 · Cited by 39 · cited 1×
“EDA cFN in particular, is essential in wound healing has been well established by our group and others (7, 38, 39 ).”
BackgroundAkiyama, S. K. (2013) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1005s60 · Cited by 20
Inoue, T., Nabeshima, K., Shimao, Y., Meng, J.-Y., & Koono, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4264 · Cited by 19 · cited 1×
“EDA cFN (also termed oncofetal or embryonic FN) is an important substrate for cell migration (40), adhesion (41), and myofibroblast differentiation (Reference 6 and data presented here).”
BackgroundKoukoulis, G. Κ., Shen, J., Virtanen, I., & Gould, V. E. (1995) · Ultrastructural Pathology · doi:10.3109/01913129509014601 · Cited by 14 · cited 1×
“Primarily, EDB FN appears to be expressed in fetal tissue and in newly generated vasculature of certain malignancies (i.e., breast and liver) (23, 24 ).”
Background
Research works printed but not linked: 3
- 1991, Am J Pathol, 138, 1257
- 1974, Am J Pathol, 77, 185
- 1993, J Submicrosc Cytol Pathol, 25, 285
Cited by
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
“More promising strategies appear to target TGF 1 profibrotic cofactors, such as CCN2(74) or the ECM protein extradomain A fibronectin.(75,76) Alternatively, TGF 1 can be counteracted at the level of its activation from latent stores; possible targets in the activation process are fibroblast/myofibroblast-associated in…”
BackgroundPulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
“Further, ED-A KO fibroblasts display a reduced response to active TGF-β [118].”
BackgroundTGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800
“The pattern of deposition of collagen is strikingly similar, and follows temporally that of fibronectin secretion, a prominent mesenchymal protein that is induced by TGF-b1 signaling (Hernnas et al. 1992; Muro et al. 2008).”
BackgroundSelf-citationThe myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
“In this regard, the EDA domain of FN is more attractive as a potential therapeutic target for the treatment of fibrotic diseases because it is a specific and crucial component of the myofibroblast ECM that is highly upregulated in a variety of fibrotic diseases but virtually absent from most normal connective tissues…”
Self-citation
Metadata
- Authors
- Muro, A. F., Moretti, F. A., Moore, B. B., Yan, M., Atrasz, R. G., Wilke, C. A., Flaherty, K. R., Martinez, F. J., Tsui, J. L., Sheppard, D., Baralle, F. E., Toews, G. B., & White, E. S.
- Affiliations
- International Centre for Genetic Engineering and Biotechnology (IT)
- University of Michigan (US)
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; and
- University of California, San Francisco (US)
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-03
- Volume
- 177
- Issue
- 6
- Pages
- 638-645
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC2267338
- OpenAlex
- W2172090615
- Cited by
- 297
- References
- 41
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 14 · 2023: 18 · 2022: 17 · 2021: 20 · 2020: 15 · 2019: 16 · 2018: 18 · 2017: 19 · 2016: 20 · 2015: 14 · 2014: 22 · 2013: 24 · 2012: 15
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL56402, P50HL056402, K08HL070990, HL070990, R01HL085083, HL085083)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- idiopathic pulmonary fibrosis, lung fibrogenesis, bleomycin-induced lung fibrosis, alpha-smooth muscle actin, myofibroblasts, TGF-beta activation, latent TGF-beta, lung fibroblasts, wound healing
- MeSH terms
- Actins, Animals, Cells, Cultured, Disease Models, Animal, Fibroblasts, Fibronectins, Humans, Pulmonary Fibrosis, Wound Healing, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.